MyHealthChecked PLC Establishment of an Employee Benefit Trust (8615V)
April 12 2023 - 2:00AM
UK Regulatory
TIDMMHC
RNS Number : 8615V
MyHealthChecked PLC
12 April 2023
MyHealthChecked PLC
( " MyHealthChecked " or the "Company " )
Establishment of an Employee Benefit Trust
MyHealthChecked PLC (AIM: MHC), the consumer home-testing
healthcare company, announces that it has established an Employee
Benefit Trust called The MyHealthChecked PLC Benefit Trust (the
"EBT"). The EBT will be for the benefit of current and future
employees.
The EBT will act independently of the Company, managed by Ogier
Global Trustee (Jersey) Limited, and is expected to make market
purchases of ordinary shares of the Company ("Ordinary Shares") in
order to, among other things, satisfy future option exercises of
vested options granted pursuant to the Company's share option
scheme.
The EBT will be funded by way of a loan from the Company and the
Board believes that the formation of the EBT will help the Company
in attracting new talent and incentivising existing members of the
management team. The maximum amount of the loan to be made
available to the EBT is currently capped at GBP50,000 but maybe
varied in the future by agreement between the Company and the
trustees of the EBT.
For further information contact:
MyHealthChecked PLC www.myhealthchecked.com
Penny McCormick, Chief Executive via Walbrook PR
Officer
SPARK Advisory Partners Limited Tel: +44 (0)20 3368 3550
(NOMAD)
Neil Baldwin
Dowgate Capital Limited (Broker) Tel: +44 (0)20 3903 7715
David Poutney / Nicholas Chambers
Walbrook PR Ltd (Media Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
& IR)
Paul McManus / Alice Woodings Mob: +44 (0)7980 541 893 / +44
(0)7407 804 654
About MyHealthChecked PLC ( www.myhealthcheckedplc.com )
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted
pioneering UK healthcare company focused on a range of at-home
healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home
rapid tests, as well as DNA, RNA and blood sample collection kits
which have been created to support customers on their journeys to
wellness. The tests are lateral-flow self-tests, and the sample
collection kits enable the collection of blood, urine nasal or
mouth swab samples that are analysed in partner laboratories for a
range of biomarkers. The tests will also be made available online
and will be viable for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a
change in mindset as customers become more familiar with the
concept of accessible healthcare in the growing at home testing kit
market with a focus on accessibility at the right price, led by
UK-based experts.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCUAASROKUSAAR
(END) Dow Jones Newswires
April 12, 2023 02:00 ET (06:00 GMT)
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From Jul 2024 to Aug 2024
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From Aug 2023 to Aug 2024